If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
388
results.
Updated on
15/11/2026 [07:48:00]
Results 325 to 350 of 388
Absstract of: US20260325081A1
An example system includes a memory; and processing circuitry coupled to the memory and configured to: receive electrocardiogram (ECG) data of a patient, wherein the ECG data is generated by one or more sensing devices of the patient based on physiological signals of the patient sensed by the one or more sensing devices; obtain a plurality of heartbeat intervals from the ECG data; sample a plurality of points for each respective heartbeat interval of the plurality of intervals; determine a slow-moving average for each sample point parameter of respective heartbeat intervals during a. first period of time; determine a fast-moving average for each sample point parameter of respective heartbeat intervals during a second period of time, determine a difference between the slow-moving average and the fast-moving average for each sample point parameter; and determine a risk level of a health event for the patient based on the determined differences.
Absstract of: AU2026242121A1
Recommendations based on continuous glucose monitoring (CGM) are described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform processes these measurements and the additional data to predict a health indicator by using models. This prediction serves as a basis for generating a recommendation, such as a message recommending the user take action or adopt a behavior to mitigate a predicted negative health condition. ep e p
Absstract of: US20260325481A1
The present disclosure provides methods for individualized selection of, and monitoring of treatment using a neurodegenerative therapeutic agent such as Sigma-1 receptor agonist therapy for a subject, based on changes in gene expression pre- and post-treatment. The present disclosure also provides methods to evaluate current status or risk of a subject in developing neurodegenerative disorders. Also provided are kits for practicing the methods.
Absstract of: US20260326382A1
0000 A method for 3D printing a patient-specific bone implant having variable density, in various aspects, comprises: (1) providing a thermoplastic polymer composition comprising: (A) between about 20% and about 50% bioactive agent by weight; (B) between about 0.5% and about 10% chemical foaming agent by weight; and (C) balance structural polymer by weight; (2) receiving, by computing hardware, a scan of a bone, the scan comprising at least a 3D image of the bone and radiodensity data for the bone; and (3) causing, by the computing hardware, a 3D printer to form the patient-specific bone implant from the 3D image using the thermoplastic polymer by modifying a 3D printing temperature of the 3D printer during printing of the patient-specific bone implant such that each portion of the patient-specific bone implant is produced at a temperature that corresponds to a desired density defined by the radiodensity data for the bone.
Absstract of: WO2025058286A1
According to an embodiment of the present disclosure, disclosed is a method for generating disease prediction information using biometric signals, which is executed by a computing device. The method may comprise the steps of: acquiring biometric signals at a diagnosis time point; acquiring past biometric signals at a previous time point before the diagnosis time point or information associated with the past biometric signals; and generating disease prediction information for the diagnosis time point on the basis of the biometric signals at the diagnosis time point and the past biometric signals at the past time point or the information associated with the past biometric signals, using a neural network model.
Absstract of: EP4826738A2
Provided are systems and methods using which users may learn and become familiar with the effects of various aspects of their lifestyle on their health, e.g., users may learn about how food and/or exercise affects their glucose level and other physiological parameters, as well as overall health. In some cases the user selects a program to try; in other cases, a computing environment embodying the system suggests programs to try, including on the basis of pattern recognition, i.e., by the computing environment determining how a user could improve a detected pattern in some way. In this way, users such as type II diabetics or even users who are only prediabetic or non-diabetic may learn healthy habits to benefit their health.
Absstract of: EP4813296A1
0001 To non-invasively identify a ventricular tachycardia exit site in a heart of a particular patient (107) using electrocardiogram signals and medical imagery for the particular patient, a control circuit (101) can be configured to access (205) a neural network (104) that has been trained (202) using a plurality of synthetic data examples (203) and to input information regarding the electrocardiogram signals and the aforementioned medical imagery for the particular patient to the neural network. The control circuit can then output from the neural network information that identifies a predicted ventricular tachycardia exit site in the heart of the particular patient.
Absstract of: GB2645382A
A patient is provided with a wristband having a unique machine-readable patient code and medical cabinet 2. Cabinet 2 has first compartment 4 for securely containing the Patient's Own Drugs (PODs) and second compartment 6 for securely containing further medicines. Authorised persons register the patient on a computer and register PODs by entering details of each POD into the computer. Authorised persons set reminder times in the computer for administration of PODs and place PODs into first compartment 4. Optionally, further medicines are placed into second compartment 6. The computer provides a reminder to the patient at each reminder time. Upon receipt of the reminder, the patient scans the wristband using a code reader. The reading of the unique patient code initiates unlocking of the door to first compartment 4, but not second compartment 6, thereby giving the patient access to a POD. Optionally, the ability of a patient to comply with self-administration of a drug treatment regime is assessed by logging the number of times a first locker is unlocked by scanning the patient's wristband and comparing the number with the number of reminders.
Absstract of: WO2026054777A1
A vision-enabled fluid flow rate detection system is disclosed. The system includes an image sensing device that images an infusion container supplying a fluid to an infusion pump and a pattern of markings associated with a surface of the container, and identifies a visual difference in the pattern from a default state of the pattern to determine a volume of fluid infused from the infusion container, and used to calculate a volume of fluid in the container and a flow rate of the fluid. When the amount of fluid, as determined by the vision system, differs from the amount reported by the pump, the pump's motor may be adjusted to correct the expected volume or flow rate, as needed. When a severe infusion inaccuracy is detected, an alarm or other indication may be provided, or the infusion terminated.
Absstract of: EP4825318A1
0001 The present disclosure provides a method and a computing device for setting a treatment order based on an emergency patient's condition. According to an embodiment of the present disclosure, a method for setting a treatment order based on an emergency patient's condition, performed by a computing device including at least one processor, comprises, when reception data of a new examinee is acquired, acquiring physiological data of the examinee via a sensing unit, analyzing the physiological data using a pre-trained neural network model to identify the new examinee's condition, and setting a treatment order for the new examinee based on a time at which the reception data of the new examinee is acquired and the new examinee's condition. The setting of the treatment order comprises setting the treatment order for the new examinee by adjusting, based on the examinee's condition, the treatment orders of the other previously registered examinees who are waiting for treatment.
Absstract of: WO2025128987A1
Described are continuous manufacturing methods using 3D printing or any similar additive manufacturing technology to produce pharmaceutical ASDs. Manufacturing methods include preparing printing ink including API and polymeric carriers. The printing ink is accurately deposited onto a deposition surface by forming printing ink droplets by using an electromagnetic DoD 3D printing device to form an ASD printed product. The ASD printed product has improved solubility and bioavailability than the API in crystalline form.
Absstract of: WO2025124483A1
Provided is an oral drug dosage form configured to be used for targeted drug delivery at a desired gastrointestinal location, methods of design and use related to the oral drug dosage form.
Absstract of: EP4826736A1
0001 The present invention relates to a computer-implemented method for predicting a patient's (P) fistula failure encompassing an inputting of a plurality of parameter values, into a computer system (1), wherein some of these values have been measured during one or more dialysis treatment sessions while treating the patient (P) using a hemodialysis treatment apparatus (100) and/or wherein some of these values are or have been calculated based on or derived from values having been measured during one or more dialysis treatment sessions while treating the patient (P) using a hemodialysis treatment apparatus (100). The computer-implemented method further encompasses a predicting of the probability of an event predefined as a fistula failure within a predetermined time period or within a predetermined number of treatment sessions. Moreover, it encompasses an outputting of the predicted probability.
Absstract of: KR20260153070A
본 발명은 체질량지수 기반 다이어트 모니터링 및 건강기능식품을 추천하는 방법 장치를 개시한다. 즉, 본 발명은 서버에서 사용자의 기본 정보, 건강 상태 정보, 특이사항, 사용자 요구 사항 등을 근거로 사용자의 현재 상태에 따른 맞춤형 건강 기능 식품을 추천하고, 단말로부터 추천된 건강 기능 식품에 대한 구독이 접수되면 구독 기간 동안 해당 건강 기능 식품을 제공함으로써, 사용자의 건강 기능 식품의 복용 편리성 및 만족도를 높일 수 있다.
Absstract of: TR2026016910A2
Buluş, gebelik döneminde idrar stripleri ile glikoz takibinin ev ortamında güvenilir bir şekilde yapılabilmesi amacıyla, standart idrar striplerinin optik olarak okunmasını, okunan verinin gebelik haftasına göre dinamik eşik değerleri, önceki ölçüm trendleri, ölçüm zamanı, strip geçerlilik kontrolü ve referans alan doğrulaması ile birlikte değerlendiren ve yalnızca doğrulanmış kritik risk durumunda kapalı devre bildirim gönderen bir akıllı takip sistemi ile bu sistemin çalışma yöntemini kapsamaktadır.
Absstract of: EP4825333A2
A dental overlay device includes a base (1013), connecting strut (1018), and veneer holder (1019). The base has a curvature in the form of an arch of a patient and defines a curved axis. The connecting strut has a first end attached to the base and a second end and extends in a generally orthogonal direction to the curved axis. The veneer holder has first and second ends and extends in a transverse direction to the direction the connecting strut extends. The second end of the connecting strut is attached to the veneer holder. A dental overlay device and veneer combination includes a first veneer and a second veneer prepared for mounting onto the plurality of teeth. Floss is configured for passing between the first veneer and the second veneer when the dental overlay device is mounted onto the plurality of teeth.
Absstract of: US2021307635A1
0001 The present disclosure provides apparatuses and methods for measurement of the biocapacitance of tissue. The apparatus comprises a sensor comprising two electrodes, a movable element coupled to the sensor, and a switch disposed between the movable element and a fixed element, wherein the switch electrically closes when a gap between the movable element and the fixed element is less than or equal to a pre-determined value. The device makes a measurement of the biocapacitance between the two electrodes when the switch closes.
Absstract of: EP4826734A2
0001 Embodiments of delivering reduced pressure wound therapy are disclosed. In some embodiments, a system includes a reduced pressure wound therapy device and a remote computer. The device can be configured to apply reduced pressure to a wound of a patient according to a default reduced pressure therapy prescription. The device can be configured to monitor usage data and transmit the usage data to the remove computer for determining compliance with a reduced therapy prescription. In some cases, non-compliance can be determined due to change of the prescription from the default prescription to a prescription more suitable for treating the wound. A non-compliance notification can be transmitted to the device. The device settings can be updated to the current prescription.
Absstract of: EP4825410A2
0001 An administration system for delivery of a pharmaceutical composition to a patient has a delivery device configured to deliver a dose of the pharmaceutical composition to the patient and a notification device in communication with the delivery device. The notification device is configured to communicate information about a status of at least one property of the delivery device. The delivery device is a wearable automatic injector configured to be worn on the patient's skin. A delivery device of the present disclosure allows a user or patient to view the status of a container. For example, a delivery device of the present disclosure provides a simple and effective visual means of displaying fill confirmation and delivery confirmation.
Absstract of: JP2021089747A
To receive glucose data from a continuous glucose sensor and control the use and redistribution of the data so that the data is used in an intended manner.SOLUTION: In one aspect, a method includes: preparing data including glucose levels using a continuous glucose sensor unit; wirelessly transmitting the data relating to the glucose levels to a display device from the continuous glucose sensor unit; automatically forwarding the data relating to the glucose levels from the display device to a cloud computing architecture; and storing the data relating to the glucose levels in separate groups at the cloud computing architecture.SELECTED DRAWING: Figure 4
Absstract of: WO2025054569A1
A device providing ocular photo-bio-stimulation therapy, a biological technique to control or influence the activity of neurons or other cell types in, on or about the eye with light. As used herein ocular photo-bio-stimulation is an umbrella category of which photobiomodulation, optogenetics and phototherapy are forms thereof. The current invention relates, in part, to photobiomodulation therapy, which includes the utilization of nonionizing electromagnetic energy to trigger photochemical changes within cellular structures. The current invention relates, in part, to optogenetics. Optogenetics is a biological technique to control the activity of neurons or other cell types with light. The current invention relates, in part, to phototherapy, also known as light therapy or bright light therapy, which is a treatment that uses controlled exposure to artificial or natural light to treat medical conditions.
Absstract of: WO2025231436A1
An expandable prosthetic device used as a prosthesis during surgery. The expandable prosthetic device is configured for use in the extremities of a body such as, but not limited to, use in the expansion of the lateral or medial column of a foot. The expandable prosthetic device includes a drive block, a linkage block, a drive screw, a first endplate, a second endplate, and first and sets of linkages. Rotation of the drive screw causes movement of the linkage block relative to the drive block and/or movement of the first endplate relative to the second endplate.
Absstract of: US20250143629A1
Methods, systems, and devices for miscarriage identification are described. A system may be configured to receive physiological data associated with a user that is pregnant and collected over a plurality of days, where the physiological data includes at least temperature data. Additionally, the system may be configured to determine a time series of temperature values. The system may then identify that the temperature values are lower than a pregnancy baseline of temperature values for the user and detect an indication of an early pregnancy loss of the user. The system may generate a message for display on a graphical user interface on a user device that indicates the indication of the early pregnancy loss.
Absstract of: US20250235265A1
0000 A method for predicting a type of surgery required for a patient comprises: receiving imaging data including at least one image acquired of a patient's anatomy; determining at least one parameter of the patient's anatomy based on the image data, the at least one parameter including at least one of a B-score and a C-score; receiving patient data regarding the patient; generating, based at least in part on the at least one parameter and the patient data, a predicted procedure for the patient; and outputting the predicted procedure for display within a graphical user interface (GUI).
Nº publicación: KR20260152675A 20/10/2026
Applicant:
VISCUS BIOLOGICS LLC [US]
\uBE44\uC2A4\uCEE4\uC2A4 \uBC14\uC774\uC62C\uB85C\uC9C1\uC2A4 \uC5D8\uC5D8\uC528
Absstract of: WO2025147712A1
The present disclosure relates generally to oral tissue repair compositions and implants thereof; and, more particularly, to customized acellular extracellular matrix repair compositions and implants for patient-specific treatment of various oral tissue defects, such as periodontal recession.
BOPI
Electronic site
